Prot# AVF3646s: Phase II Study of Radiation Followed by Paclitaxel, Carboplatin, and Bevacizumab (PCA) in Patients with Stage IIIB and IV Squamous Non-Small Cell Lung Cancer (NU Prot# NU 05L1)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/4/06 → 2/1/12

Funding

  • Genentech, Inc (AVF3646s)